Encompass Health Corporation found using ticker (EHC) now have 11 analysts covering the stock. The analyst consensus points to a rating of ‘Strong_Buy’. The target price ranges between 76 and 66 and has a mean target at 71.45. Given that the stocks previous close was at 55.25 this indicates there is a potential upside of 29.3%. The day 50 moving average is 60.34 while the 200 day moving average is 53.32. The market cap for the company is $5,467m. Visit the company website at: https://www.encompasshealth.com
The potential market cap would be $7,070m based on the market concensus.
Encompass Health Corporation provides post-acute healthcare services in the United States. It provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides services under the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.
